WASHINGTON - surgery appears to be a better option for treatment of prostate cancer at the beginning that "waiting under surveillance", particularly for younger patients, according to a Swedish study published Thursday.
In the first clinical trial examines the impact of the removal through surgery of the prostate, the monitoring team 347 patients selected at random for the procedure and closely watched 348 others, according to the study in the New England Journal of Medicine.
Assessment of nearly 700 men, averaged 65 when diagnosed, concluded that after 15 years, 48% of men in the surgical group dies, compared to 58% in the Group closely monitored.
For the surgical group, 16 per cent died of prostate cancer, compared to 23% for the watched.
The risk of cancer spread "beyond the prostate was less than 12% for those who have received surgery."
The study found that young men in the study, elderly about 65 - benefited more surgery, all passing under the knife presented fewer benefits for elderly patients.
"Not everyone enjoys surgery, kind of individual risks and potential gains should be evaluated based on the age, other diseases, tumor type and preferences of patients," warned Anna Bill-Axelson, head physician at the Department of surgery at the University of Uppsala in Sweden.
Patients whose tumors surgery grew beyond the prostate also ran a "risk seven times liked death" because of prostate cancer that those whose tumors confined to the gland, also warned the report.
No comments:
Post a Comment